Welcome to our dedicated page for Ferrovial SE SEC filings (Ticker: FER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ferrovial’s toll roads from Texas to Madrid and its airport stakes pack one annual report with concession accounting, passenger-flow metrics and multi-currency debt notes. If you have ever searched, “Ferrovial’s quarterly earnings report 10-Q filing” or “Ferrovial insider trading Form 4 transactions,” you know the challenge: hundreds of pages, four business segments and industry-specific jargon. Investors need Ferrovial SEC filings explained simply.
Stock Titan solves the problem. Our AI-powered summaries translate a dense 10-K into plain English, showing how shifts in traffic volume hit revenue or when concession deadlines move. Real-time alerts stream Ferrovial Form 4 insider transactions, while interactive timelines put every 8-K material event in context—think “Ferrovial 8-K material events explained” delivered as soon as EDGAR posts. Ask a natural question such as “understanding Ferrovial SEC documents with AI” or “Ferrovial proxy statement executive compensation,” and the platform surfaces the exact section you need.
You can then dive deeper: Ferrovial annual report 10-K simplified for concession maturities, Ferrovial earnings report filing analysis for quarter-over-quarter airport EBITDA, or Ferrovial executive stock transactions Form 4 to monitor buying and selling patterns. Comprehensive coverage means every filing type—10-Q, 10-K, 8-K, Form 4—arrives with AI context, segment breakouts and real-time updates. The result: informed decisions on dividend capacity, construction backlog risk or potential asset sales without wading through technical appendices.
Brown & Brown, Inc. (NYSE: BRO) disclosed in an 8-K that it completed a $4.2 billion multi-tranche senior notes offering on 23 June 2025.
The company sold six series of unsecured notes: $400 MM 4.600% due 2026, $500 MM 4.700% due 2028, $800 MM 4.900% due 2030, $500 MM 5.250% due 2032, $1.0 BN 5.550% due 2035 and $1.0 BN 6.250% due 2055. Interest is payable semi-annually every 23 June and 23 December, beginning 23 Dec 2025.
Use of proceeds: together with cash and the previously announced equity sale of 43,137,254 shares, the funds will finance the cash consideration for the pending acquisition of RSC Topco, Inc. and related fees. If the merger is not consummated by the contractual outside date, the company must redeem the 2026, 2028, 2030, 2032 and 2055 notes at 101% of par plus accrued interest (the 2035 notes are excluded from this mandatory redemption).
The notes were issued under the company’s existing shelf (S-3 333-271708) and rank pari passu with all other senior unsecured debt. The governing indenture restricts the incurrence of secured debt, significant asset transfers, and contains a change-of-control put. Optional redemption is allowed subject to make-whole premiums defined in the prospectus supplement. Holland & Knight LLP provided the legality opinion.
Completion of this financing secures long-term, fixed-rate capital for the RSC transaction and extends BRO’s debt maturity profile to 2055, albeit at coupons that reflect the current higher-rate environment and will increase the company’s leverage and interest expense.
Key Transaction. Cyclacel Pharmaceuticals has secured a $3 million private placement by issuing 3 million Series F Convertible Preferred shares at $1.00 each and 29.43 million five-year warrants (strikes $0.51/$0.60/$0.68). Each preferred share converts into 3.27 common shares, representing 9.81 million potential shares.
Dilution Effect. If all preferred shares are converted and all warrants exercised, common shares outstanding could rise from 23.76 million to ≈63.0 million (+165%), well above Nasdaq’s 20% dilution threshold, hence the need for shareholder approval under Listing Rule 5635(d).
Approval Mechanics. On 18 June 2025, CEO Datuk Dr. Doris Wong (holder of 51.2% voting power) delivered written consent approving (i) conversion share issuance, (ii) warrant issuance, and (iii) amendment to the Series F Certificate of Designations to remove the 4.99% ownership blocker. No proxy or meeting is required; the action becomes effective ≥20 days after the 7 July 2025 mailing (earliest 27 July 2025).
Capital & Liquidity. Cash and equivalents were ≈$3.45 million on 31 March 2025 and management disclosed “substantial doubt” about going-concern status. The new capital is earmarked for general corporate and operating needs and may extend the cash runway but does not fully resolve long-term funding requirements.
Governance & Rights. Series F shares vote with common stock on an as-converted basis, participate in dividends, and rank pari passu with other preferred shares for $1.00 stated value on liquidation. Until the Series F amendment is effective, conversions/exercises remain capped at 4.99% ownership per investor.
Investor Takeaway. The financing provides short-term liquidity and preserves Nasdaq listing compliance but introduces significant dilution risk and reinforces majority control by the CEO.
FAQ
What is the current stock price of Ferrovial SE (FER)?
What is the market cap of Ferrovial SE (FER)?
What are the main business segments of Ferrovial SE?
How does Ferrovial generate revenue?
On which stock exchanges is Ferrovial SE listed?
How does Ferrovial’s business model mitigate risks?
What distinguishes Ferrovial SE in the infrastructure sector?
How does Ferrovial adapt to technological advancements?
What geographic markets does Ferrovial SE operate in?
How does Ferrovial SE manage large infrastructure projects?
What role do strategic collaborations play at Ferrovial?
